Literature DB >> 21286925

Polyneuropathy and dementia in old age: common inflammatory and vascular parameters.

Friedrich Leblhuber1, Katharina Schroecksnadel, Margit Beran-Praher, Herbert Haller, Kostja Steiner, Dietmar Fuchs.   

Abstract

Thirty-three inpatients (22 females, 11 males, aged 79.4 ± 9.5 years) were investigated in this prospective cohort study to study the prevalence of polyneuropathy (PNP) and dementia in geriatric inpatients. Clinical and electrodiagnostic investigations, routine laboratory, including thyroid parameters, folic acid, vitamin B(12), homocysteine, neopterin, fibrinogen and glycosylated hemoglobin were measured in serum, the mini-mental state examination and computed tomographic scanning were performed in each patient. PNP was found clinically and electrodiagnostically in 96% of patients. Age was the most precipitating factor for PNP, and was significantly correlated to electrodiagnostic changes in the nerves investigated in both, upper and lower extremities, while clinical symptoms were confined only to the feet. Correlation was seen between homocysteine and the amplitude of the sural nerve (surAmpl) (rs = -0.406, p = 0.029) as well as the sural nerve conduction velocity (surNCV) (rs = -0.389, p = 0.037), and between neopterin and the grade of denervation (rs = 0.445, p = 0.014) in our patients. Neopterin and fibrinogen did not correlate significantly, but there was a trend to higher fibrinogen concentrations in patients with higher neopterin levels (rs = 0.344, p = 0.062). A trend of a correlation was seen between higher homocysteine concentrations and the number of changes in electrodiagnostic measurements (rs = 0.354, p = 0.055). Twenty-one of the 33 patients (64%) were demented, 9 (27%) presented clinically as mild cognitive impairment, 3 (9%) were not demented. Vascular risk factors were found in 83%: hypertension in 58%, hypercholesterinemia in 39%, cardiac disease in 36%, diabetes mellitus (DM) in 21%, peripheral arterial disease (PAD) in 9%. A significant correlation was found between homocysteine and folic acid concentrations (rs = -0.401, p = 0.028). Falls were reported in 48% of cases, indicating PNP as a risk factor in this group of patients. In conclusion, PNP was found very common with a high coincidence with dementia and a female preponderance, suggesting an influence on daily life (falls) in our subjects studied. PNP correlated significantly with markers for vascular disease as well as immune activation (homocysteine and neopterin) similar to earlier findings in patients with neurodegenerative disorders, suggesting common therapeutic options in patients with PNP and dementia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286925     DOI: 10.1007/s00702-011-0579-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  22 in total

1.  Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy.

Authors:  N Hattori; K Misu; H Koike; M Ichimura; M Nagamatsu; M Hirayama; G Sobue
Journal:  J Neurol Sci       Date:  2001-02-15       Impact factor: 3.181

Review 2.  Cytokines and cognition--the case for a head-to-toe inflammatory paradigm.

Authors:  Craig J Wilson; Caleb E Finch; Harvey J Cohen
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

Review 3.  Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.

Authors:  N Weiss
Journal:  Curr Drug Metab       Date:  2005-02       Impact factor: 3.731

4.  Hyperhomocysteinemia in dementia.

Authors:  F Leblhuber; J Walli; E Artner-Dworzak; K Vrecko; B Widner; G Reibnegger; D Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

5.  Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

Authors:  F Licastro; S Pedrini; L Caputo; G Annoni; L J Davis; C Ferri; V Casadei; L M Grimaldi
Journal:  J Neuroimmunol       Date:  2000-02-01       Impact factor: 3.478

6.  Association of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels.

Authors:  Katharina Schroecksnadel; Friedrich Leblhuber; Barbara Frick; Barbara Wirleitner; Dietmar Fuchs
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Jul-Sep       Impact factor: 2.703

Review 7.  Current and future strategies for the management of diabetic neuropathy.

Authors:  Rayaz A Malik
Journal:  Treat Endocrinol       Date:  2003

8.  Cryptogenetic polyneuropathies: an out-patient follow-up study.

Authors:  F Grahmann; M Winterholler; B Neundörfer
Journal:  Acta Neurol Scand       Date:  1991-09       Impact factor: 3.209

9.  Elevated levels of plasma homocysteine are associated with neurotoxicity.

Authors:  Robertus H C Bisschops; Yolanda van der Graaf; Willem P Th M Mali; Jeroen van der Grond
Journal:  Atherosclerosis       Date:  2004-05       Impact factor: 5.162

10.  Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study.

Authors:  Lisa H Colbert; Marjolein Visser; Eleanor M Simonsick; Russell P Tracy; Anne B Newman; Stephen B Kritchevsky; Marco Pahor; Dennis R Taaffe; Jennifer Brach; Susan Rubin; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2004-07       Impact factor: 5.562

View more
  1 in total

1.  Macrophage Depletion Ameliorates Peripheral Neuropathy in Aging Mice.

Authors:  Xidi Yuan; Dennis Klein; Susanne Kerscher; Brian L West; Joachim Weis; Istvan Katona; Rudolf Martini
Journal:  J Neurosci       Date:  2018-04-30       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.